LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $36,854,529
Key CONT_AWD_75N91022F00007_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 494 days before this system saw it. One version on record.
Cite this row
a44e4f8917a52db3b6496a9d8a891bba5b934a15d898cdfd011993323e7ba1caThe source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $36,854,529 | first version | March 7, 2022 | April 29, 2025 | 2026-09-05T00:54:37Z | historical sweep | a44e4f8917a5 |
Archived copy
https://web.archive.org/web/20261011033427/https://www.usaspending.gov/award/CONT_AWD_75N91022F00007_7529_75N91019D00024_7529 captured by this system, October 11, 2026
What the amount is made of
6 recorded actions, so the amount is the award's current total across all of them. 2 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $36,854,529.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| April 24, 2025 | P00005 | TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL) | no money | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI |
| December 20, 2023 | P00004 | OTHER ADMINISTRATIVE ACTION | no money | THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS |
| May 16, 2023 | P00003 | OTHER ADMINISTRATIVE ACTION | no money | THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS |
| December 14, 2022 | P00002 | OTHER ADMINISTRATIVE ACTION | no money | THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS |
| July 28, 2022 | P00001 | DEFINITIZE LETTER CONTRACT | +$14,653,976 | THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS |
| March 7, 2022 | base | not on file | +$22,200,553 | THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS |
Last refreshed November 4, 2026 at 2:31 PM UTC.